Targeting cardiac fibroblasts to treat fibrosis of the heart: Focus on HDACs von Schuetze, Katherine B, McKinsey, Timothy A, Long, Carlin S

Volltext

Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention von Valle, Javier A, Glorioso, Thomas J, Schuetze, Katherine B, Grunwald, Gary K, Armstrong, Ehrin J, Waldo, Stephen W

Volltext

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes von Williams, Sarah M, Golden-Mason, Lucy, Ferguson, Bradley S, Schuetze, Katherine B, Cavasin, Maria A, Demos-Davies, Kim, Yeager, Michael E, Stenmark, Kurt R, McKinsey, Timothy A

Volltext

Substrate stiffness modulates cardiac fibroblast activation, senescence, and proinflammatory secretory phenotype von Felisbino, Marina B, Rubino, Marcello, Travers, Joshua G, Schuetze, Katherine B, Lemieux, Madeleine E, Anseth, Kristi S, Aguado, Brian A, McKinsey, Timothy A

Volltext

HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling von Demos-Davies, Kimberly M, Ferguson, Bradley S, Cavasin, Maria A, Mahaffey, Jennifer H, Williams, Sarah M, Spiltoir, Jessica I, Schuetze, Katherine B, Horn, Todd R, Chen, Bo, Ferrara, Claudia, Scellini, Beatrice, Piroddi, Nicoletta, Tesi, Chiara, Poggesi, Corrado, Jeong, Mark Y, McKinsey, Timothy A

Volltext

Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking Program von Valle, Javier A, Glorioso, Thomas J, Schuetze, Katherine B, Grunwald, Gary K, Armstrong, Ehrin J, Waldo, Stephen W

Volltext

Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts von Schuetze, Katherine B., Stratton, Matthew S., Blakeslee, Weston W., Wempe, Michael F., Wagner, Florence F., Holson, Edward B., Kuo, Yin-Ming, Andrews, Andrew J., Gilbert, Tonya M., Hooker, Jacob M., McKinsey, Timothy A.

Volltext

TNAP: a new player in cardiac fibrosis? Focus on "Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts" von Schuetze, Katherine B, McKinsey, Timothy A

Volltext

The potential of targeting epigenetic regulators for the treatment of fibrotic cardiac diseases von Schuetze, Katherine B, Koch, Keith A, McKinsey, Timothy A

Volltext

Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition von Cavasin, Maria A, Demos-Davies, Kimberly M, Schuetze, Katherine B, Blakeslee, Weston W, Stratton, Matthew S, Tuder, Rubin M, McKinsey, Timothy A

Volltext

Suppression of pathological cardiac fibrosis by histone deacetylase inhibitors von Schuetze, Katherine B, McKinsey, Timothy A

Volltext

BRD4 inhibition rewires cardiac macrophages toward a protective phenotype marked by low MHC class II expression - Supplemental Figures von Katherine B., Schuetze

Volltext bestellen

Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study von von Mehren, Margaret, George, Suzanne, Heinrich, Michael C, Schuetze, Scott M, Yap, Jeffrey T, Yu, Jain Q, Abbott, Amanda, Litwin, Samuel, Crowley, John, Belinsky, Martin, Janeway, Katherine A, Hornick, Jason L, Flieder, Douglas B, Chugh, Rashmi, Rink, Lori, Van den Abbeele, Annick D

Volltext